Fluticasone Propionate HFA Inhaler Cost Without Insurance (Generic Flovent)

The generic fluticasone propionate HFA inhaler, the authorized generic that replaced brand-name Flovent HFA, has an average retail price of $276.06 for one 110 mcg inhaler without insurance, according to GoodRx pricing data last updated July 16, 2026. A GoodRx discount coupon can bring that same product down to as low as $160.27 at participating pharmacies. These are national average figures, not a quote for any single pharmacy or ZIP code, so your local price may be higher or lower. If you were searching for “prescription-strength fluticasone” expecting a nasal spray price, see the title note above: the nasal spray version of fluticasone is now sold over the counter, typically for $8 to $25, and this article covers the inhaler instead, since that is the fluticasone product that still requires a prescription.

Prescription Versus Over-the-Counter Fluticasone

This distinction is worth stating plainly before any pricing discussion. Fluticasone propionate nasal spray at 50 mcg per spray, used for allergy symptoms, is FDA-approved for over-the-counter sale and does not require a prescription for adults and children 4 and older. Fluticasone furoate nasal spray (the active ingredient in Flonase Sensimist) is also available OTC. Neither of these requires a prescription discount card comparison in the way this article covers, since OTC cash prices are already low and are not billed through prescription insurance in the same way.

The fluticasone propionate inhaler, used as a daily controller medication for asthma, is a different product entirely. It requires a prescription, it is not available over the counter, and it is the product this article addresses.

What the Generic Flovent Inhaler Actually Is

Fluticasone propionate HFA is an inhaled corticosteroid delivered by a metered-dose inhaler, indicated for the maintenance treatment of asthma in patients 4 years and older, according to its FDA-approved prescribing information listed on DailyMed. It comes in three strengths, 44 mcg, 110 mcg, and 220 mcg per actuation, and each canister contains 120 metered inhalations. The 44 mcg canister holds 10.6 grams; the 110 mcg and 220 mcg canisters hold 12 grams. A typical prescribed regimen uses two inhalations twice daily, which generally makes one canister last about a month, though your prescriber determines your specific regimen.

Brand-name Flovent HFA and Flovent Diskus were discontinued by their manufacturer, GSK, at the start of 2024. Only the authorized generic versions, fluticasone propionate HFA and fluticasone propionate Diskus, remain on the market. In late 2025, the FDA also approved an additional, independently manufactured generic fluticasone propionate inhalation aerosol from Glenmark, which the FDA’s Center for Drug Evaluation and Research described as expanding access to more affordable asthma treatment.

The HFA and Diskus versions are two different delivery devices for the same active ingredient. The HFA is a pressurized metered-dose inhaler that releases a measured spray with each actuation. The Diskus is a dry powder inhaler that the patient activates by inhaling a breath-actuated dose, with no propellant involved. Because these are separate manufactured devices with separate production processes, they are priced independently, and a price for one should never be assumed to apply to the other. According to the product’s FDA-approved labeling on DailyMed, patients using either device are advised to rinse the mouth with water after each use without swallowing, since inhaled corticosteroids carry a labeled risk of oral candidiasis (thrush) if residue is left in the mouth and throat. This is general safety information from the manufacturer’s label, not a substitute for your prescriber’s specific instructions.

Current Cash and Discount-Card Prices

The table below reflects a single, specific product, so it does not need to be combined with pricing for any other fluticasone formulation.

For context only, and not to be combined with the figures above, GoodRx’s national average retail price for the OTC fluticasone propionate nasal spray (non-prescription, 50 mcg/spray, 120 metered sprays) was $27.76, with a discount-card price as low as $16.85, checked the same date. This is a separate product with a separate price and is included here only to show why “prescription-strength fluticasone” pricing and inhaler pricing are not the same question.

Prices for both the 44 mcg and 220 mcg strengths of the HFA inhaler differ from the 110 mcg figures above, and pricing also varies for the Diskus (dry powder) delivery form. If your prescription is for a different strength or device, confirm current pricing for that exact product rather than assuming it matches the 110 mcg HFA figures.

Why Prices Vary by Formulation, Strength, Device, Quantity, Pharmacy, Manufacturer, and Location

Several independent factors affect what you pay for this specific inhaler.

Formulation and device matter because the HFA metered-dose inhaler and the Diskus dry powder inhaler are manufactured differently and are priced as separate products, even though both deliver fluticasone propionate.

Strength affects price because each strength, 44, 110, and 220 mcg, is manufactured and priced somewhat independently, similar to how different milligram strengths of any drug are treated as distinct products.

Quantity matters if your prescriber has written for more than one canister at a time, since per-unit pricing can shift with quantity.

Pharmacy matters because acquisition costs, markup, and any discount-card network participation vary by pharmacy and pharmacy chain.

Manufacturer matters now that more than one company, including the original authorized generic manufacturer and Glenmark’s newer generic, produce a version of this inhaler. Multiple manufacturers competing for the same product can influence pricing over time.

Location matters because pharmacy pricing can vary by state and by ZIP code, even within the same pharmacy chain.

Insurance Price Versus Cash Price

Your insurance copay for this inhaler depends entirely on your specific plan’s formulary placement for fluticasone propionate HFA, which changed for many plans after the 2024 brand discontinuation and the shift to generic-only availability. Some plans place the generic in a low-cost tier; others may require prior authorization or step therapy. Your cash price, what you would pay with no insurance applied, is a completely separate number set by the pharmacy, and a discount-card price is a third, separately negotiated number. There is no reliable way to predict your exact copay from the cash price shown here, so confirming your specific plan’s cost-sharing directly with your insurer or pharmacy is the only way to know your actual copay.

Formulary placement for this drug has been particularly unsettled since the brand discontinuation. Some insurers initially kept Flovent-branded products listed on their formularies even after the manufacturer stopped supplying them, which created confusion at the pharmacy counter when the branded product simply was not available to be dispensed. Many plans have since updated their formularies to explicitly cover the authorized generic and any newly approved generic alternatives, but coverage details still vary by plan and by state. If your copay seems unexpectedly high or your pharmacy tells you the drug is not covered, it is worth asking your insurer whether their formulary has been updated to reflect current generic availability, since this is a documented source of billing friction industry-wide following the 2024 transition.

Responsible Ways to Reduce the Cost

A few concrete, low-risk options exist for this specific medication.

Ask your prescriber whether a manufacturer copay program applies to your situation. GSK’s copay cap program, which can bring certain brand inhalers to as low as $35 per month for eligible commercially insured patients, applies to GSK’s current branded products such as Arnuity Ellipta, Breo Ellipta, and Trelegy Ellipta. It does not apply to the authorized generic fluticasone propionate HFA, so this option is only relevant if your prescriber determines a covered brand alternative is appropriate for you.

Ask about GSK’s patient assistance program for uninsured patients who may qualify based on income, since manufacturer assistance programs are typically separate from copay cards and have their own eligibility rules.

Compare cash and discount-card prices across more than one pharmacy before filling, since acquisition costs and markup differ by pharmacy as noted above.

Ask your prescriber whether a 90-day supply is appropriate for your treatment plan, since some patients find a larger supply lowers the effective per-canister cost, though this depends on your specific regimen and monitoring needs.

Ask your pharmacist which manufacturer’s generic they currently stock, since more than one company now produces fluticasone propionate HFA. As additional generic manufacturers have entered the market following the 2024 brand discontinuation, pricing has started to shift, and a pharmacy that recently added a newer generic supplier may offer a different price than one still sourcing from the original authorized generic manufacturer. This is a reasonable question to ask, and it does not require your prescriber’s involvement, since any FDA-approved generic version of the same strength and device is considered therapeutically equivalent.

How to Compare the Exact Product Through NuLifeSpanRX

Once your prescriber has confirmed your prescribed product, strength, and device, a NuLifeSpanRX discount card lets you search for that exact fluticasone propionate HFA (or Diskus) prescription and compare cash prices at pharmacies in the NuLifeSpanRX network, side by side with what you might otherwise pay through insurance. As with the discount-card figures shown above, actual pricing, participation, and savings vary by pharmacy and location and are never guaranteed. A discount card is not insurance and generally cannot be combined with an insurance claim on the same fill. For more on how cash, copay, and discount-card pricing relate to one another, see our guide on insurance price versus cash price.

Why Different Fluticasone Formulations Are Not Interchangeable

Fluticasone propionate nasal spray, fluticasone propionate inhaler, fluticasone propionate topical cream, and fluticasone furoate products all contain fluticasone, but they are formulated for entirely different routes of administration and different conditions. A nasal spray cannot be used in place of an inhaler for asthma, and an inhaler is not used for allergy or skin symptoms. Never substitute one fluticasone product for another, and never assume that because two products share an active ingredient name, they are equivalent in dose, delivery, or approved use. Any change to your prescribed medication, device, or strength should be made only in consultation with your prescriber and pharmacist.

Frequently Asked Questions

How much does prescription-strength fluticasone cost without insurance?

If you mean the nasal spray commonly labeled “prescription strength,” that product is now sold over the counter and typically costs $8 to $25 without insurance. If you mean the fluticasone inhaler used for asthma, which is the fluticasone product that still requires a prescription, the average retail price is $276.06 for one 110 mcg canister, based on GoodRx pricing data checked July 16, 2026, with discount-card pricing as low as $160.27.

Is fluticasone nasal spray still available by prescription?

The standard 50 mcg/spray fluticasone propionate formulation used for allergy symptoms is available over the counter and does not require a prescription. A separate prescription-only nasal product, Xhance, uses a different delivery device for chronic sinus conditions and is not the same as standard allergy nasal spray.

Why did Flovent become more expensive or harder to find?

GSK discontinued brand-name Flovent HFA and Flovent Diskus at the start of 2024. Only authorized generic versions remain, and some pharmacies and insurance plans took time to update their stock and formularies after the transition, which affected both availability and coverage for some patients.

Can I use fluticasone nasal spray instead of my fluticasone inhaler to save money?

No. These are different formulations approved for different conditions and different routes of administration. A nasal spray does not treat asthma and is not a substitute for an inhaled controller medication. Any change to your prescribed treatment should be discussed with your prescriber.

Does a manufacturer copay card lower the cost of generic fluticasone propionate HFA?

Not directly. GSK’s copay cap program applies to its current brand-name inhalers, not to the authorized generic fluticasone propionate HFA. If cost is a concern, ask your prescriber whether a copay-cap-eligible brand product might be clinically appropriate, or compare cash and discount-card prices for the generic instead.